To validate our previous results regarding the nuclear distribution of KLF6 in ERBB2-overexpressing breast tumors the expression of Estrogen Receptor alpha was determined as an additional established risk factor for breast cancer. This evidence concerns the gene ERBB2 and breast neoplasm.